1. Home
  2. REAL vs VYGR Comparison

REAL vs VYGR Comparison

Compare REAL & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The RealReal Inc.

REAL

The RealReal Inc.

HOLD

Current Price

$9.14

Market Cap

1.9B

ML Signal

HOLD

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

HOLD

Current Price

$3.96

Market Cap

194.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
REAL
VYGR
Founded
2011
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
194.0M
IPO Year
2019
2015

Fundamental Metrics

Financial Performance
Metric
REAL
VYGR
Price
$9.14
$3.96
Analyst Decision
Buy
Strong Buy
Analyst Count
8
3
Target Price
$17.00
$21.00
AVG Volume (30 Days)
3.0M
868.8K
Earning Date
05-07-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
43.55
N/A
EPS
N/A
N/A
Revenue
$692,845,000.00
$10,135,000.00
Revenue This Year
$14.30
$33.19
Revenue Next Year
$10.19
$14.68
P/E Ratio
N/A
N/A
Revenue Growth
15.38
N/A
52 Week Low
$4.61
$2.65
52 Week High
$17.39
$5.55

Technical Indicators

Market Signals
Indicator
REAL
VYGR
Relative Strength Index (RSI) 41.40 47.45
Support Level $7.21 $3.72
Resistance Level $11.17 $4.30
Average True Range (ATR) 0.52 0.23
MACD 0.11 -0.03
Stochastic Oscillator 49.08 28.88

Price Performance

Historical Comparison
REAL
VYGR

About REAL The RealReal Inc.

The RealReal is the largest pure-play luxury resale platform in the US, generating $1.8 billion in 2024 gross merchandise volume and addressing a niche (personal luxury resale) that had previously been serviced by inefficient upscale boutiques and local pawn shops. The company generates revenue via consignment and first-party sales on its online marketplace, and through a small volume of direct sales. With a hands-on approach that actively sources inventory and authenticates every item on its platform, The RealReal is able to justify much higher take rates than peers, working out to roughly 36% of net merchandise value in 2024, which excludes returns, cancellations, and first-party sales.

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

Share on Social Networks: